Medicines in China's National Health Insurance System
portes grátis
Medicines in China's National Health Insurance System
Foundation, China Development Research
Taylor & Francis Ltd
05/2024
Mole
9781032351131
Pré-lançamento - envio 15 a 20 dias após a sua edição
Descrição não disponível.
1. Research on dynamic mechanisms for adjusting the national list of reimbursable drugs 2. Research on drug procurement mechanisms 3. Research on drug pricing mechanisms 4. Research on drug payment and usage 5. Research on the role of commercial health insurance in reimbursing drug costs 6. Research on drug pricing mechanisms in other countries
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
Basic Medical Insurance;Medical Insurance;Chinese Studies;HTA;Health Technology Assessments;Pharmacy Benefit Managers;Price Formation Mechanisms;Drug Prices;GPOs;Innovative Drugs;Medical Insurance Funds;Centralized Procurement;Medical Insurance System;Commercial Health Insurance;Reimbursement Price;Drug Procurement;Critical Illness Insurance;Commercial Health Insurance Companies;Patient Access Scheme;Payment Standards;Reimbursement Standards;Centralized Bidding;Drug Manufacturers;Urban Employees Basic Medical Insurance;Generic Drugs;Long Term Care Insurance
1. Research on dynamic mechanisms for adjusting the national list of reimbursable drugs 2. Research on drug procurement mechanisms 3. Research on drug pricing mechanisms 4. Research on drug payment and usage 5. Research on the role of commercial health insurance in reimbursing drug costs 6. Research on drug pricing mechanisms in other countries
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
Basic Medical Insurance;Medical Insurance;Chinese Studies;HTA;Health Technology Assessments;Pharmacy Benefit Managers;Price Formation Mechanisms;Drug Prices;GPOs;Innovative Drugs;Medical Insurance Funds;Centralized Procurement;Medical Insurance System;Commercial Health Insurance;Reimbursement Price;Drug Procurement;Critical Illness Insurance;Commercial Health Insurance Companies;Patient Access Scheme;Payment Standards;Reimbursement Standards;Centralized Bidding;Drug Manufacturers;Urban Employees Basic Medical Insurance;Generic Drugs;Long Term Care Insurance
